Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis Patients
Objectives: For rheumatoid arthritis (RA) patients failing to achieve treatment targets with conventional synthetic disease-modifying antirheumatic drugs, tumor necrosis factor (TNF)-? inhibitors (anti-TNF therapies) are the primary first-line biologic therapy. In a cross-cohort, cross-platform stud...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Mary Ann Liebert
2020-07-01
|
| Series: | Network and Systems Medicine |
| Online Access: | https://www.liebertpub.com/doi/full/10.1089/NSM.2020.0007 |